H.R. 1627 119th Congress House

TREATS Act

Official title: To amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment, and for other purposes.

Introduced: February 26, 2025 Introduced by: Donald Norcross Democratic · New Jersey See on congress.gov

Health Drug, alcohol, tobacco useHealth technology, devices, suppliesMental health

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Feb 26, 2025

Introduced in House

Feb 26, 2025

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now February 26, 2025

Plain-English summary Congressional Research Service

Telehealth Response for E-prescribing Addiction Therapy Services Act or the TREATS Act

This bill permanently allows health care practitioners to prescribe certain controlled substances for treating substance use disorders via telehealth without evaluating the patient in person.

Generally, a health care practitioner may not prescribe a controlled substance via telehealth unless they first conduct an in-person medical evaluation. Federal regulations currently provide a temporary exception to this requirement, allowing practitioners to prescribe schedule II-V controlled substances for legitimate medical purposes (such as treating substance use disorders) via telehealth without an in-person evaluation. However, this temporary regulatory flexibility expires on December 31, 2025.

The bill permanently allows practitioners to prescribe schedule III-V controlled substances for the treatment of a substance use disorder via telehealth without conducting an in-person evaluation. In such instances, a practitioner may conduct a telehealth evaluation using audio-only or audio and video equipment.

Related & companion bills 1

Bill text 1 version

Introduced in House Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

Committees of jurisdiction 2

Energy and Commerce Committee
House of Representatives
Judiciary Committee
House of Representatives

Lobbying activity 51

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

BCBSM, INC.
for BCBSM INC · Minnesota · 3rd Quarter 2026 (July 1 - Sep 30)
AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)
for AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
SIRONA STRATEGIES LLC
for ALLIANCE FOR CONNECTED CARE · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
AMERICAN ASSOCIATION OF NURSE PRACTITIONERS
for AMERICAN ASSOCIATION OF NURSE PRACTITIONERS · Virginia · 3rd Quarter 2026 (July 1 - Sep 30)
ATA ACTION
for ATA ACTION · Virginia · 3rd Quarter 2026 (July 1 - Sep 30)
ADVANCED POLICY CONSULTING, LLC
for ATA ACTION · Virginia · 3rd Quarter 2026 (July 1 - Sep 30)

Bodies those filers lobbied

HOUSE OF REPRESENTATIVES
51 filings
SENATE
51 filings
Health & Human Services, Dept of (HHS)
42 filings
Centers For Medicare and Medicaid Services (CMS)
28 filings
Executive Office of the President (EOP)
27 filings
White House Office
25 filings
Drug Enforcement Administration (DEA)
24 filings
Labor, Dept of (DOL)
18 filings

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

See all 51 filings →

Cosponsors 31